Death on Gene Therapy Trial
In the fall of 1999, 18-year-old Jesse Gelsinger died as a result of his participation in a gene transfer trial. Jesse had a rare metabolic disorder, ornithine transcarbamylase deficiency syndrome (OTC) that was being controlled by medication and diet. Researchers were testing an innovative technique using adenovirus gene transfer. Shortly after treatment Jesse Gelsinger experienced multiple organ failure and subsequently died. This case catapulted research with human subjects into the national media. Serious concerns related to conflict of interest, data safety monitoring, and informed consent have made the Gelsinger case a contemporary illustration of continued doubts about the ethical integrity of research with human subjects. This case has instigated deliberations on all these controversial topics at the national level. The outcome of the discussions has yet to be determined.
Hmm wikipedia has more info than the crappy citi test I'm taking
Random trash talk: "Stynky you really want to keep eating herbicide fill, genetically modified animals and plants?"
EXP Podcast #758: The 2024 Gamey Awards
-
*2024 Gamey Host*
The most prestigious video game award show is back, celebrating once again
not just the greatest bummers and mood lifters, but also the...
11 hours ago
No comments:
Post a Comment